key: cord-0990085-vn2q43ui
authors: Thwin, Ohnmar; Grobe, Nadja; Tapia Silva, Leticia M.; Ye, Xiaoling; Zhang, Hanjie; Wang, Yuedong; Kotanko, Peter
title: SARS-CoV-2 Seropositivity Rates in Patients and Clinical Staff in New York City Dialysis Facilities: Association With the General Population
date: 2021-04-20
journal: Kidney Med
DOI: 10.1016/j.xkme.2021.02.010
sha: 78fd3d3846955fa20e6885ae2306e06b04cbf134
doc_id: 990085
cord_uid: vn2q43ui

nan

To the Editor:

There are concerns that in-center maintenance hemodialysis (HD) patients may have a higher risk for infection with SARS-CoV-2, because they take three or more round-trips a week to dialysis centers and spend several hours during dialysis close to fellow patients and clinic staff. This concern is supported by data from dialysis facilities in London, U.K. 1 During the first wave of COVID-19, New York City was one of the worst affected regions in the U.S. Starting in August 2020, the New York City Department of Health (NYC DOH) has published regularly updated seropositivity rates for the general population for most 5-digit zipcode areas. 2 This allowed us to link zipcode area seroprevalence data with the results of 2 cross-sectional serosurveillance projects conducted in in-center maintenance HD patients and clinic staff in Manhattan dialysis facilities.

Between June and September 2020, we conducted a quality improvement project and an IRB-approved clinical research study (Western IRB Protocol # 20201875) to assess the prevalence of SARS-CoV-2 antibodies in in-center maintenance HD patients and clinic staff. The quality improvement project was approved by the clinic governing bodies and underwent legal and compliance review. Verbal consent was obtained from all patients. Written informed consent was obtained from staff prior to blood sampling.

Blood samples were obtained and analyzed for IgG and IgM antibodies by Spectra J o u r n a l P r e -p r o o f Laboratories (Rockleigh, NJ, USA) using the emergency use authorized kits with reported specificity and sensitivity of 98.7% and 100%. 3 Zipcode seropositivity rates were calculated by dividing the number of seropositive RRI in-center maintenance HD patients by the number of all RRI patients living in that area. We used simple weighted linear regression and Spearman's rank correlation to estimate the correlation between general population and patient seroprevalence rates across all applicable zipcodes. In an aggregate analysis, the staff seropositivity rate of 16.5% was significantly lower than the 30.3% seropositivity observed in patients (P = 0.005). Analysis on a clinic level revealed a lower seropositivity rate in staff compared to patients in 2 clinics (clinics A and D) and no significant difference in clinics B and C. ( Table 1) Our results indicate a significant correlation between general population and incenter hemodialysis patient seropositivity rates for SARS-CoV-2 infection and support the notion that COVID-19 in in-center maintenance HD patients is primarily driven by infections in the patients' residence area. 4 The lower seropositivity rates in dialysis staff compared to patients points towards the effectiveness of screening measures and efforts to limit transmission in dialysis centers.

providing key data to inform infection control. We found a seroprevalence rate of 30.3% among in-center maintenance HD patients residing in a region with high COVID-19 prevalence; this finding corroborates a nationwide serosurveillance study in 1,300 dialysis clinics. 5 An analysis per zipcode in the clinic staff was not possible due to the small number of staff residences in zipcode areas with reported seroprevalence rates and the dispersion of staff residences across a large number of zipcode areas, resulting in a small number of staff members per zipcode. Of note, staff seroprevalence rates were lower compared to that of patients in 2 out of 4 clinics.

We are aware of some limitations. First, general population seropositivity rates were either not available in all zipcode areas or the number of patients and staff living in specific area was too small. Second, more research is needed to investigate the J o u r n a l P r e -p r o o f relationship between socio-economic indicators and COVID-19 seropositivity rates across different regions.

In summary, our results indicate an association between patient and general population seropositivity rates. Seropositivity rates were higher in patients compared to clinic staff. 

COVID-19 prevalence and seroconversion in an urban hemodialysis unit in the United Kingdom

Hemodialysis international International Symposium on Home Hemodialysis

Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19

Comparative analysis of COVID-19 reproduction rates in the dialysis and general populations

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. The Lancet

Figure 1: Association between seropositivity rates in the general population (x-axis)

The dashed lines are the 95% confidence interval for the weighted linear regression. The equation of the fitted line is: Patient Positive Rate = 1.31 × General Population Positive Rate

The slope of the regression line does not differ significantly from the line of identify